Go Deep
Biofrontera Inc.
Biofrontera Inc. Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 19,610 | -2.0 | 2.11 | 1.26 | 80.23 |
| Oct 2026 | 19,719 | -1.9 | 2.05 | 1.26 | 77.82 |
| Oct 2026 | 17,987 | -1.9 | 2.01 | 1.26 | 76.39 |
| Oct 2026 | 17,994 | -1.9 | 2.00 | 1.26 | 76.23 |
| Oct 2026 | 18,011 | -1.9 | 2.00 | 1.26 | 75.67 |
| Oct 2026 | 18,092 | -1.8 | 1.95 | 1.26 | 73.72 |
Biofrontera Inc. Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | 12,003,000.0 | 10,084,000.0 | 17,100,000.0 | 6,988,000.0 |
| Net Profit | -604,000.0 | -4,752,000.0 | 5,640,000.0 | -6,649,000.0 |
| EPS | -0.1 | -0.4 | 0.5 | -0.6 |
Biofrontera Inc. Revenue & Profit: Last 5 Years
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Revenue | 41,705,000.0 | 37,321,000.0 | 34,071,000.0 | 28,674,000.0 | — |
| Net Profit | -10,536,000.0 | -17,759,000.0 | -20,131,000.0 | -640,000.0 | — |
| EPS | -0.9 | -3.2 | -13.0 | -0.5 | — |
Biofrontera Inc. Balance Sheet
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Total Assets | 28,564,000.0 | 22,101,000.0 | 27,932,000.0 | 50,884,000.0 | — |
| Total Liabilities | 18,084,000.0 | 17,668,000.0 | 23,139,000.0 | 27,006,000.0 | — |
| Total Equity | 10,480,000.0 | 4,433,000.0 | 4,793,000.0 | 23,878,000.0 | — |
Owes vs Owns
Biofrontera Inc. owed $0.75 for every $1 it owned in Jun 2026, up from $0.53 in Dec 2022.
| Period | Jun 2026 | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|---|
| Owes vs Owns | 0.75× | 0.63× | 0.80× | 0.83× | 0.53× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
Biofrontera Inc. Assets & Liabilities Breakdown (USD millions)
What it owns — Dec 2025
Cash & short-term investments 22.4%Receivables 29.8%Inventory 5.0%Fixed assets (tangible) 13.1%Intangible assets 9.3%Other assets 20.4%
How it's funded — Dec 2025
Short-term debt 1.2%Long-term debt 16.1%Payables 6.5%Other liabilities 39.6%Shareholders' equity 36.7%
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 6.4 | 5.9 | 1.4 | 27.8 |
| Receivables | 8.5 | 5.4 | 5.2 | 7.4 |
| Inventory | 1.4 | 6.6 | 10.9 | 7.2 |
| Fixed assets (tangible) | 3.7 | 1.0 | 1.7 | 1.6 |
| Intangible assets | 2.6 | 0.0 | 2.6 | 3.0 |
| Long-term investments | 0.0 | 0.0 | 0.0 | 0.0 |
| Other assets | 5.8 | 3.2 | 6.1 | 3.9 |
| Liabilities & equity | ||||
| Short-term debt | 0.3 | 0.5 | 3.9 | 0.5 |
| Long-term debt | 4.6 | 4.1 | 0.8 | 0.8 |
| Payables | 1.9 | 1.9 | 3.3 | 1.3 |
| Other liabilities | 11.3 | 11.2 | 15.1 | 24.4 |
| Shareholders' equity | 10.5 | 4.4 | 4.8 | 23.9 |
| Net tangible assets | 7.8 | 4.4 | 2.2 | 20.8 |
Biofrontera Inc. Cash Flow
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Operating Activities | -13,361,000.0 | -10,270,000.0 | -24,895,000.0 | -16,199,000.0 | — |
| Investing Activities | 2,998,000.0 | -3,000.0 | 619,000.0 | -5,156,000.0 | — |
| Financing Activities | 10,850,000.0 | 14,835,000.0 | 8,411,000.0 | 14,021,000.0 | — |